The SAB was first appointed in 2011 and then reappointed from 2015. It consists of six internationally renowned scientists that meet NCMBM core members every 12-24 months.
Members of the Scientific Advisory Board
- Prof. Richard Treisman, Director of CRUK London Research Institute, London, UK and Research Director, the Francis Crick Institute, London,UK (Chair of SAB)
- Ewan Birney, Director of EMBL-EBI, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
- Edith Heard, CEO of the Francis Crick Institute, London, UK
- Prof. Olli Kallioniemi, Director SciLifeLab, Stockholm, Sweden
- Prof. George Vassiliou, Professor of Haematological Medicine, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge
- Dr. Judith Zaugg, Research Group Leader, Department of Biomedicine, University of Basel, Switzerland.